Pacira BioSciences (PCRX) EBITDA Margin (2010 - 2026)
Pacira BioSciences (PCRX) posted EBITDA Margin of 13.29% for Q2 2026, down 6.49 percentage points from 19.78% a year earlier and down 2.63 percentage points from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) EBITDA Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Pacira BioSciences was 14.08%, up 16.11 percentage points year-over-year; for FY2025, it came in at 15.17%, up 14.40 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of -0.25 percentage points (FY2020 to FY2025).
- In prior years, Pacira BioSciences' EBITDA Margin was 0.77% in FY2024 (-23.41 pp), 24.19% in FY2023 (+1.46 pp), 22.72% in FY2022 (+0.85 pp) and 21.88% in FY2021 (+6.46 pp).
- Quarterly EBITDA Margin has run from a low of -70.76% in Q3 2024 to a high of 34.77% in Q2 2023 over five years.
- On a year-over-year basis, EBITDA Margin increased in two of the last eight quarters, with an average year-over-year change of -4.92 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q3 2025, with a gain of 86.10 percentage points; the weakest was Q3 2024, with a drop of 92.81 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 15.92% (Q1 2026), 12.03% (Q4 2025) and 15.35% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Pacira BioSciences | 1.02 Bn | 83.47 Mn | 148.24 Mn | 13.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.29% |
| Mar 31, 2026 | 15.92% |
| Dec 31, 2025 | 12.03% |
| Sep 30, 2025 | 15.35% |
| Jun 30, 2025 | 19.78% |
| Mar 31, 2025 | 13.71% |
| Dec 31, 2024 | 24.54% |
| Sep 30, 2024 | -70.76% |
| Jun 30, 2024 | 26.46% |
| Mar 31, 2024 | 18.93% |
| Dec 31, 2023 | 28.50% |
| Sep 30, 2023 | 22.06% |
| Jun 30, 2023 | 34.77% |
| Mar 31, 2023 | 10.30% |
| Dec 31, 2022 | 11.93% |
| Sep 30, 2022 | 24.77% |
| Jun 30, 2022 | 30.75% |
| Mar 31, 2022 | 23.69% |
| Dec 31, 2021 | 10.86% |
| Sep 30, 2021 | 29.10% |
API Access
Pacira BioSciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();